Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Solid Tumor × 5-fluorouridine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumor 1

Interventions

ulixertinib 1 toripalimab 1 spartalizumab 1 famitinib 1 erdafitinib 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Injections 1 Gemcitabine 1 Docetaxel 1 Cisplatin 1 Capecitabine 1 5-fluorouridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05148195 2024-03-13

A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 2 Terminated

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡